<?xml version="1.0" encoding="UTF-8"?>
<fig id="antioxidants-09-01273-f008" orientation="portrait" position="float">
 <label>Figure 8</label>
 <caption>
  <p>Methodological design based on the biotechnological strategy “increasing income and reducing expenditure” proposed by Zhang et al. [
   <xref rid="B200-antioxidants-09-01273" ref-type="bibr">200</xref>] for improving RA production. CCR, cinnamoyl-CoA reductase; CCoAMT, caffeoyl-CoA O methyltransferase; C3′H, coumarate 3′-hydroxylase; C4H, cinnamate 4-hydroxylase; 4CL, hydroxycinnamate-CoA ligase; COMT, caffeic acid O-methyltransferase; GT, glycosyl transferase; HCT, hydroxycinnamoyl transferase; HPPR, hydroxyphenylpyruvate reductase; PAL, phenylalanine ammonia lyase; RAS, rosmarinic acid synthase; TAT, tyrosine aminotransferase.
  </p>
 </caption>
 <graphic xlink:href="antioxidants-09-01273-g008" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</fig>
